{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:58:08Z","timestamp":1791291488790,"version":"4.3.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.2353\/ajpath.2008.071049","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T21:58:12Z","timestamp":1210283892000},"page":"1650-1663","source":"Crossref","is-referenced-by-count":190,"title":["CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma"],"prefix":"10.1016","volume":"172","author":[{"given":"Ayumi","family":"Yoshizaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihide","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Muroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Tedder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2008.071049_bib1","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Antinuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.2353\/ajpath.2008.071049_bib3","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.2353\/ajpath.2008.071049_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/ard.53.9.574","article-title":"Phenotypic and functional activation of alveolar macrophages. T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjogren's syndrome","volume":"53","author":"Gudbjornsson","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.2353\/ajpath.2008.071049_bib5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.2353\/ajpath.2008.071049_bib6","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2008.071049_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000082087","article-title":"The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system","volume":"8","author":"Tedder","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"10.2353\/ajpath.2008.071049_bib8","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib9","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.186.11.1923","article-title":"CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes","volume":"186","author":"Inaoki","year":"1997","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2008.071049_bib10","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib11","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/art.20674","article-title":"Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis","volume":"50","author":"Tsuchiya","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.2353\/ajpath.2008.071049_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molimm.2004.06.025","article-title":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis","volume":"41","author":"Sato","year":"2004","journal-title":"Mol Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.2353\/ajpath.2008.071049_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2008.071049_bib15","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/sj.jid.5700919","article-title":"BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice","volume":"127","author":"Matsushita","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.2353\/ajpath.2008.071049_bib16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","article-title":"B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis","volume":"169","author":"Hasegawa","year":"2006","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2008.071049_bib17","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.2353\/ajpath.2008.071049_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.2353\/ajpath.2008.071049_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","article-title":"The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?","volume":"297","author":"Yamamoto","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.2353\/ajpath.2008.071049_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","article-title":"Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule","volume":"3","author":"Engel","year":"1995","journal-title":"Immunity"},{"key":"10.2353\/ajpath.2008.071049_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.2353\/ajpath.2008.071049_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1525-1578(10)60652-6","article-title":"A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR","volume":"3","author":"Meijerink","year":"2001","journal-title":"J Mol Diag"},{"key":"10.2353\/ajpath.2008.071049_bib23","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.4049\/jimmunol.162.12.7088","article-title":"CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation","volume":"162","author":"Fujimoto","year":"1999","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib24","first-page":"2628","article-title":"Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W\/W(V) mice","volume":"26","author":"Yamamoto","year":"1999","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s004030000183","article-title":"Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains","volume":"292","author":"Yamamoto","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.2353\/ajpath.2008.071049_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI6094","article-title":"Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice","volume":"104","author":"Nakao","year":"1999","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2008.071049_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1164\/ajrccm.156.6.9611057","article-title":"Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study","volume":"156","author":"Yaekashiwa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.2353\/ajpath.2008.071049_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-102-2-182","article-title":"Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?","volume":"102","author":"Hawkins","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.2353\/ajpath.2008.071049_bib29","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2008.071049_bib30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/thx.2005.056317","article-title":"In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung","volume":"61","author":"Nakagome","year":"2006","journal-title":"Thorax"},{"key":"10.2353\/ajpath.2008.071049_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jlb.64.4.528","article-title":"TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury","volume":"64","author":"Smith","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.2353\/ajpath.2008.071049_bib32","first-page":"L1255","article-title":"Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis","volume":"285","author":"Segel","year":"2003","journal-title":"Am J Physiol"},{"key":"10.2353\/ajpath.2008.071049_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.autrev.2004.05.001","article-title":"Mast cells and autoimmunity","volume":"4","author":"Rottem","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.2353\/ajpath.2008.071049_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0753-3322(94)90005-1","article-title":"Cytokines and macrophages","volume":"48","author":"Cavaillon","year":"1994","journal-title":"Biomed Pharmacother"},{"key":"10.2353\/ajpath.2008.071049_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2172-5-15","article-title":"Age-associated alterations in CXCL1 chemokine expression by murine B cells","volume":"5","author":"Hu","year":"2004","journal-title":"BMC Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib36","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.154.5.2393","article-title":"Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines","volume":"154","author":"Taub","year":"1995","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib37","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.161.5.2600","article-title":"Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells","volume":"161","author":"Lippert","year":"1998","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib38","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2004-11-4205","article-title":"IgE- and IgE+Ag-mediated mast cell migration in an autocrine\/paracrine fashion","volume":"105","author":"Kitaura","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2008.071049_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/taap.1997.8275","article-title":"Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure","volume":"147","author":"Ishii","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.2353\/ajpath.2008.071049_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2008.071049_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4049\/jimmunol.172.1.20","article-title":"Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4","volume":"172","author":"Johnson","year":"2004","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib42","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1315","article-title":"Regulation of lung injury and repair by Toll-like receptors and hyaluronan","volume":"11","author":"Jiang","year":"2005","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2008.071049_bib43","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2008.071049_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1078\/0171-9335-00392","article-title":"Hyaluronan catabolism: a new metabolic pathway","volume":"83","author":"Stern","year":"2004","journal-title":"Eur J Cell Biol"},{"key":"10.2353\/ajpath.2008.071049_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","article-title":"Hyaluronan fragments: an information-rich system","volume":"85","author":"Stern","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"10.2353\/ajpath.2008.071049_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2353\/ajpath.2006.050923","article-title":"Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response","volume":"168","author":"Matsushita","year":"2006","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2008.071049_bib47","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.4049\/jimmunol.152.12.5860","article-title":"Transforming growth factor-beta 1 mediates mast cell chemotaxis","volume":"152","author":"Gruber","year":"1994","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nature05165","article-title":"Immunology: protection and privilege","volume":"442","author":"Waldmann","year":"2006","journal-title":"Nature"},{"key":"10.2353\/ajpath.2008.071049_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib52","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/eji.200636483","article-title":"TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells","volume":"37","author":"Barr","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.20021850","article-title":"Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling","volume":"197","author":"Choe","year":"2003","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2008.071049_bib54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"10.2353\/ajpath.2008.071049_bib55","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1161\/01.CIR.0000101921.93016.1C","article-title":"Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction","volume":"108","author":"Shishido","year":"2003","journal-title":"Circulation"},{"key":"10.2353\/ajpath.2008.071049_bib56","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib57","first-page":"308","article-title":"Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis","volume":"25","author":"Hasegawa","year":"1998","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib58","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4),. IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib59","first-page":"2838","article-title":"Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis","volume":"27","author":"Sato","year":"2000","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2008.071049_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1011024313525","article-title":"Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation","volume":"21","author":"Valentini","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.2353\/ajpath.2008.071049_bib61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2002-11-3573","article-title":"CD19 regulates innate immunity by the Toll-like receptor RP105 signaling in B lymphocytes","volume":"102","author":"Yazawa","year":"2003","journal-title":"Blood"},{"key":"10.2353\/ajpath.2008.071049_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400460","article-title":"Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease","volume":"6","author":"Rosen","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.2353\/ajpath.2008.071049_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1084\/jem.184.2.765","article-title":"Selective cleavage of nuclear autoantigens during CD95 (Fas\/APO-1)-mediated T cell apoptosis","volume":"184","author":"Casiano","year":"1996","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2008.071049_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogeneic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2008.071049_bib65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.0022-202X.2003.22121.x","article-title":"Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma","volume":"122","author":"Yamamoto","year":"2004","journal-title":"J Invest Dermatol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010619232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010619232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T02:35:27Z","timestamp":1684377327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010619232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0002944010619232"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2008.071049","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1115277.571295","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1115277.571283","asserted-by":"object"}]},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}